+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


Eiger BioPharmaceuticals Inc (EIGR) - Financial and Strategic SWOT Analysis Review

  • ID: 4284696
  • SWOT Analysis
  • March 2018
  • 25 pages
  • GlobalData
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.


Eiger BioPharmaceuticals Inc (Eiger), formerly Celladon Corp, is a clinical-stage biopharmaceutical company that focuses on the development and commercializationof novel drugs for the treatment of orphan diseases. The company’s pipeline products comprise Lonafarnib and Lambda, which are in Phase 2 trials used for the treatment of hepatitis delta virusinfection; Exendin 9-39, a phase 2 program for post-bariatric hypoglycemia;Ubenimex, a phase 2 program for lymphedema and pulmonary arterial hypertension.Eiger is headquartered in Palo Alto, California, the US.

Eiger BioPharmaceuticals Inc Key Recent Developments

Jan 08, 2018: Eiger BioPharmaceuticals Announces Appointment of Commercial Operations Industry Veteran Eldon Mayer to its Board of Directors
Jan 03, 2018: Eiger BioPharmaceuticals Appoints David Apelian, MD, PhD, MBA Chief Operating Officer and Executive Medical Officer
Jan 02, 2018: Eiger BioPharmaceuticals to Present at Biotech Showcase™ 2018
Nov 09, 2017: Eiger BioPharmaceuticals Reports Third Quarter 2017 Financial Results
Sep 18, 2017: Eiger Announces Appointment of Biopharmaceutical Industry Veteran Evan Loh, MD to its Board of Directors

This comprehensive SWOT profile of Eiger BioPharmaceuticals Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of the author’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, the author’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Eiger BioPharmaceuticals Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
*Note: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Product cover images may vary from those shown
Section 1 - About the Company
  • Eiger BioPharmaceuticals Inc - Key Information
  • Eiger BioPharmaceuticals Inc - Overview
  • Eiger BioPharmaceuticals Inc - Key Employees
  • Eiger BioPharmaceuticals Inc - Key Employee Biographies
  • Eiger BioPharmaceuticals Inc - Key Operational Heads
  • Eiger BioPharmaceuticals Inc - Major Products and Services
  • Eiger BioPharmaceuticals Inc - History
  • Eiger BioPharmaceuticals Inc - Company Statement
  • Eiger BioPharmaceuticals Inc - Locations And Subsidiaries
  • Eiger BioPharmaceuticals Inc - Key Manufacturing facilities
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Eiger BioPharmaceuticals Inc - Business Description
  • Eiger BioPharmaceuticals Inc - Corporate Strategy
  • Eiger BioPharmaceuticals Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • Eiger BioPharmaceuticals Inc - Strengths
  • Eiger BioPharmaceuticals Inc - Weaknesses
  • Eiger BioPharmaceuticals Inc - Opportunities
  • Eiger BioPharmaceuticals Inc - Threats
  • Eiger BioPharmaceuticals Inc - Key Competitors
Section 3 - Company Financial Performance Charts
  • Eiger BioPharmaceuticals Inc - Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Appendix
  • Appendix
  • Methodology
  • Ratio Definitions
  • About
  • Contact
  • Disclaimer
*Note: Some sections may be missing if data is unavailable for the company

List of Tables
  • Eiger BioPharmaceuticals Inc, Key Information
  • Eiger BioPharmaceuticals Inc, Key Ratios
  • Eiger BioPharmaceuticals Inc, Share Data
  • Eiger BioPharmaceuticals Inc, Major Products and Services
  • Eiger BioPharmaceuticals Inc, History
  • Eiger BioPharmaceuticals Inc, Key Employees
  • Eiger BioPharmaceuticals Inc, Key Employee Biographies
  • Eiger BioPharmaceuticals Inc, Key Operational Heads
  • Eiger BioPharmaceuticals Inc, Other Locations
  • Eiger BioPharmaceuticals Inc, Subsidiaries
  • Eiger BioPharmaceuticals Inc, Key Manufacturing facilities
  • Eiger BioPharmaceuticals Inc, Key Competitors
  • Eiger BioPharmaceuticals Inc, SWOT Analysis
  • Eiger BioPharmaceuticals Inc, Ratios based on current share price
  • Eiger BioPharmaceuticals Inc, Annual Ratios
  • Eiger BioPharmaceuticals Inc, Interim Ratios
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Eiger BioPharmaceuticals Inc, Performance Chart
  • Eiger BioPharmaceuticals Inc, Ratio Charts
Note: Product cover images may vary from those shown